Iron oxide particles are a class of nanoparticles composed primarily of iron oxides such as magnetite (Fe₃O₄) and maghemite (γ-Fe₂O₃), exhibiting unique magnetic properties and biocompatibility that have positioned them as versatile tools across scientific and biomedical research. Their nanoscale size, typically ranging from tens to a few hundred nanometers depending on the synthesis method, enables a high surface area-to-volume ratio, facilitating diverse surface functionalization and enhanced interaction with biological systems. The ability to manipulate their magnetic behavior allows their use in magnetic resonance imaging (MRI), targeted drug delivery, hyperthermia therapy, and biosensing applications, among others.

Key Characteristics of Iron Oxide Particles

• Composed mainly of magnetite and maghemite phases, with crystallinity and morphology influenced by synthesis conditions such as pH and precursor concentration.
• Exhibit superparamagnetic behavior at nanoscale, a property harnessed in medical imaging and therapeutic applications.
• High surface area supports efficient surface modification for targeted delivery and multifunctional platform development.
• Generally biocompatible but their potential toxicity depends on particle size, coating, and administration route, necessitating detailed toxicological evaluation.

Biomedical Applications

• Magnetic Resonance Imaging (MRI): Iron oxide nanoparticles serve as contrast agents, enhancing the visualization of tissues such as tumors and inflamed myocardium.
• Drug Delivery: Targeted delivery vehicles for chemotherapeutics or gene therapy payloads, often leveraging magnetic guidance for site-specific accumulation.
• Hyperthermia Therapy: Localized heating induced by an alternating magnetic field to selectively kill cancer cells.
• Biosensing and Diagnostics: Nanozymes mimicking enzymatic activity for biochemical detection and environmental applications.